http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20130042269-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_259045c6eba6e2c5d338b84e0a88b571 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D225-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D225-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 |
| filingDate | 2011-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8fda32d631971b319a15be9d3882dca6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_641c789b2a4a4b7b0d21df5845862877 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_432d15fb03d6a3ef38a33c01e1a9c2bd |
| publicationDate | 2013-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20130042269-A |
| titleOfInvention | Non-quinone geldanamycin sugar transfer derivative with increased solubility, or a pharmaceutically acceptable salt thereof, preparation method thereof and pharmaceutical composition for inhibiting heat shock protein (HTS90) ATPase activity |
| abstract | The present invention relates to a non-quinone geldanamycin sugar transfer derivative or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition for inhibiting heat shock protein ATPase activity thereof. The non-quinone geldanamycin glycotransfer derivatives according to the present invention are introduced into the non-quinone geldanamycin derivatives of the prior art, so that the solubility is increased, the bioavailability is increased, and the anti-tipiac inhibitory activity is excellent. It can be usefully used as an anticancer, antibiotic, antifungal, antiviral, immunosuppressive, neurodegenerative agent or anti-inflammatory. |
| priorityDate | 2011-10-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 99.